SCI

8June

PembrolizumaborPlaceboPlusEtoposideandPlatinumasFirst-LineTherapyforExtensive-StageSmall-CellLungCancer:Randomized,Double-Blind,PhaseIIIKEYNOTE-Study

CharlesM.Rudin;MarkM.Awad;AlejandroNavarro,etal.PlatinumasFirst-LineTherapyforExtensive-StageSmall-CellLungCancer:Randomized,Double-Blind,PhaseIIIKEYNOTE-Study.journalofclinicaloncology.

PURPOSE目的

Pembrolizumabmonotherapyhasshownantitumoractivityinpatientswithsmall-celllungcancer(SCLC).Therandomized,double-blind,phaseIIIKEYNOTE-study